Generate a tailored SOP for Dr. Stefani Spranger. Improve your application with a focused, well-structured draft.
Stefani Spranger is an Associate Professor in the Department of Biology at the Massachusetts Institute of Technology (MIT). She holds bachelor's and master's degrees from Ludwig-Maximilians University in Munich and obtained her PhD in 2011 from the Helmholtz-Zentrum Munich, Institute of Molecular Immunology, under the supervision of Professor Dolores J. Schendel. She completed postdoctoral training at the University of Chicago in the laboratory of Professor Thomas F. Gajewski. Dr. Spranger has been honored with a postdoctoral fellowship from the German Research Foundation and has also received the Cancer Research Institute's Irvington Postdoctoral Fellowship. Her research focuses on the interactions between cancer and the immune system, aiming to enhance existing immunotherapies and develop novel therapeutic approaches. Specifically, her work investigates how tumor microenvironments influence the efficacy of immunotherapies, particularly through the role of CD8 T cells. Dr. Spranger is a co-founder of Danger Bio and serves on the scientific advisory boards of several biotechnology companies. She has contributed to significant advancements in immunotherapy and is actively involved in designing strategies to improve cancer treatments.
Massachusetts Institute of Technology • Cambridge, MA
Teaching and conducting research in the field of biology, specifically focusing on cancer immunology and therapeutic interventions.